XML 92 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value of Assets and Liabilities Fair Value of Assets and Liabilities (Tables)
3 Months Ended
Mar. 31, 2015
Fair Value Disclosures [Abstract]  
Schedule Of Fair Value Assets and Liabilities Measured on Recurring Basis Table Text Block
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2015 and December 31, 2014 are summarized below (dollars in thousands):
March 31, 2015:
 
 
 
Fair Value Measurements Using:
 
 
Total    
 
Level 1        
 
Level 2    
 
Level 3    
Assets:
 
 
 
 
 
 
 
 
Fixed maturity securities – available-for-sale:
 
 
 
 
 
 
 
 
Corporate securities
 
$
15,179,135

 
$
141,501

 
$
13,750,655

 
$
1,286,979

Canadian and Canadian provincial governments
 
3,893,739

 

 
3,893,739

 

Residential mortgage-backed securities
 
1,127,674

 

 
935,095

 
192,579

Asset-backed securities
 
1,098,112

 

 
488,676

 
609,436

Commercial mortgage-backed securities
 
1,534,274

 

 
1,440,405

 
93,869

U.S. government and agencies securities
 
473,408

 
385,705

 
59,947

 
27,756

State and political subdivision securities
 
429,771

 

 
387,896

 
41,875

Other foreign government supranational and foreign government-sponsored enterprises
 
2,065,110

 
273,890

 
1,776,018

 
15,202

Total fixed maturity securities – available-for-sale
 
25,801,223

 
801,096

 
22,732,431

 
2,267,696

Funds withheld at interest – embedded derivatives
 
19,769

 

 

 
19,769

Cash equivalents
 
376,508

 
376,508

 

 

Short-term investments
 
59,931

 
36,465

 
23,466

 

Other invested assets:
 
 
 
 
 
 
 
 
Non-redeemable preferred stock
 
94,374

 
86,382

 

 
7,992

Other equity securities
 
40,245

 
40,245

 

 

Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
100,290

 

 
100,290

 

CPI swaps
 
(386
)
 

 
(386
)
 

Credit default swaps
 
9,781

 

 
9,781

 

Equity options
 
38,747

 

 
38,747

 

Foreign currency swaps
 
116,588

 

 
116,588

 

FVO contractholder-directed unit-linked investments
 
136,597

 
131,932

 
4,665

 

Other
 
12,480

 
12,480

 

 

Total other invested assets
 
548,716

 
271,039

 
269,685

 
7,992

Other assets – longevity swaps
 
8,602

 

 

 
8,602

Total
 
$
26,814,749

 
$
1,485,108

 
$
23,025,582

 
$
2,304,059

Liabilities:
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities – embedded derivatives
 
$
1,132,270

 
$

 
$

 
$
1,132,270

Other liabilities:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
17,784

 

 
17,784

 

Foreign currency forwards
 
10,514

 

 
10,514

 

Credit default swaps
 
384

 

 
384

 

Foreign currency swaps
 
32

 

 
32

 

Forward purchase commitments
 
5,749

 

 
5,749

 

Mortality swaps
 
1,276

 

 

 
1,276

Total
 
$
1,168,009

 
$

 
$
34,463

 
$
1,133,546

December 31, 2014:
 
 
 
Fair Value Measurements Using:
 
 
Total    
 
Level 1        
 
Level 2    
 
Level 3    
Assets:
 
 
 
 
 
 
 
 
Fixed maturity securities – available-for-sale:
 
 
 
 
 
 
 
 
Corporate securities
 
$
14,885,583

 
$
115,822

 
$
13,459,334

 
$
1,310,427

Canadian and Canadian provincial governments
 
3,865,265

 

 
3,865,265

 

Residential mortgage-backed securities
 
1,037,896

 

 
849,802

 
188,094

Asset-backed securities
 
1,069,586

 

 
496,626

 
572,960

Commercial mortgage-backed securities
 
1,532,591

 

 
1,445,845

 
86,746

U.S. government and agencies securities
 
525,851

 
437,129

 
60,193

 
28,529

State and political subdivision securities
 
426,076

 

 
383,365

 
42,711

Other foreign government, supranational and foreign government-sponsored enterprises
 
2,138,124

 
285,995

 
1,832,466

 
19,663

Total fixed maturity securities – available-for-sale
 
25,480,972

 
838,946

 
22,392,896

 
2,249,130

Funds withheld at interest – embedded derivatives
 
22,094

 

 

 
22,094

Cash equivalents
 
899,846

 
899,846

 

 

Short-term investments
 
45,190

 
21,536

 
23,654

 

Other invested assets:
 
 
 
 
 
 
 
 
Non-redeemable preferred stock
 
99,363

 
91,450

 
9

 
7,904

Other equity securities
 
27,497

 
27,497

 

 

Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
84,578

 

 
84,578

 

Interest rate options
 
18,195

 

 
18,195

 

CPI swaps
 
(561
)
 

 
(561
)
 

Credit default swaps
 
8,606

 

 
8,606

 

Equity options
 
35,242

 

 
35,242

 

Foreign currency swaps
 
70,906

 

 
70,906

 

FVO contractholder-directed unit-linked investments
 
140,344

 
134,749

 
5,595

 

Other
 
6,420

 
6,420

 

 

Total other invested assets
 
490,590

 
260,116

 
222,570

 
7,904

Other assets - longevity swaps
 
7,727

 

 

 
7,727

Total
 
$
26,946,419

 
$
2,020,444

 
$
22,639,120

 
$
2,286,855

Liabilities:
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities – embedded derivatives
 
$
1,085,166

 
$

 
$

 
$
1,085,166

Other liabilities:
 

 

 

 

Derivatives:
 

 

 

 

Interest rate swaps
 
12,957

 

 
12,957

 

Foreign currency forwards
 
15,011

 

 
15,011

 

Credit default swaps
 
419

 

 
419

 

Forward purchase commitments
 
13,370

 

 
13,370

 

Mortality swaps
 
797

 

 

 
797

Total
 
$
1,127,720

 
$

 
$
41,757

 
$
1,085,963

Fair Value Unobservable Input Measurements [Table Text Block]
The following table presents quantitative information about significant unobservable inputs used in Level 3 fair value measurements that are developed by the Company, which does not include unobservable Level 3 asset and liability measurements provided by third parties, as of March 31, 2015 and December 31, 2014 (dollars in thousands):
 
March 31, 2015:
 
 
 
Valuation Technique
 
Unobservable Inputs
 
Range (Weighted Average) 
 
Fair Value      
 
 
 
Assets:
 
 
 
 
 
 
 
 
State and political subdivision securities
 
$
5,038

 
Market comparable securities    
 
Liquidity premium
 
1
%
Corporate securities
 
221,072

 
Market comparable securities
 
Liquidity premium
 
0-2% (1%)

U.S. government and agencies
 
27,985

 
Market comparable securities
 
Liquidity premium
 
0-1% (1%)

Funds withheld at interest- embedded derivatives
 
19,769

 
Total return swap
 
Mortality
 
0-100%  (2%)

 
 
 
 
 
 
Lapse
 
0-35%  (7%)

 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
 
 
 
 
 
CVA
 
0-5%  (1%)

 
 
 
 
 
 
Crediting rate
 
2-4%  (3%)

Longevity swaps
 
8,602

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
 
 
 
 
 
Mortality improvement
 
(10%)-10%  (3%)

Liabilities:
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities- embedded derivatives- indexed annuities
 
947,857

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
 
 
 
 
 
Lapse
 
0-35%  (7%)

 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
 
 
 
 
 
Option budget projection
 
2-4%  (3%)

 
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities- embedded derivatives- variable annuities
 
184,413

 
Discounted cash flow
 
Mortality
 
0-100% (2%)

 
 
 
 
 
 
Lapse
 
0-25% (9%)

 
 
 
 
 
 
Withdrawal
 
0-7% (3%)

 
 
 
 
 
 
CVA
 
0-5% (1%)

 
 
 
 
 
 
Long-term volatility
 
0-27% (10%)

Mortality swaps
 
1,276

 
Discounted cash flow
 
Mortality
 
0-100%  (1%)


 
December 31, 2014:
 
Fair Value
 
Valuation Technique(s)
 
Unobservable Input
 
Range (Weighted Average) 
 
 
Assets:
 
 
 
 
 
 
 
 
 
State and political subdivision securities
 
$
4,994

 
Market comparable 
securities
 
Liquidity premium
 
1
%
 
Corporate securities
 
205,392

 
Market comparable
securities
 
Liquidity premium
 
0-2%  (1%)

 
U.S. government and agencies securities
 
28,530

 
Market comparable
securities
 
Liquidity premium
 
0-1%  (1%)

 
Funds withheld at interest- embedded derivatives
 
22,094

 
Total return swap
 
Mortality
 
0-100%  (2%)

 
 
 
 
 
 
 
Lapse
 
0-35%  (7%)

 
 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
 
 
 
 
 
 
CVA
 
0-5%  (1%)

 
 
 
 
 
 
 
Crediting rate
 
2-4%  (3%)

 
Longevity swaps
 
7,727

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
 
 
 
 
 
 
Mortality improvement
 
(10%)-10%  (3%)

 
 
 

 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities- embedded derivatives- indexed annuities
 
925,887

 
Discounted cash flow
 
Mortality
 
0-100% (2%)

 
 
 
 
 
 
 
Lapse
 
0-35% (7%)

 
 
 
 
 
 
 
Withdrawal
 
0-5% (3%)

 
 
 

 
 
 
Option budget projection
 
2-4% (3%)

 
Interest sensitive contract liabilities- embedded derivatives- variable annuities
 
159,279

 
Discounted cash flow
 
Mortality
 
0-100% (2%)

 
 
 
 
 
 
 
Lapse
 
0-25% (8%)

 
 
 
 
 
 
 
Withdrawal
 
0-7% (3%)

 
 
 
 
 
 
 
CVA
 
0-5% (1%)

 
 
 
 
 
 
 
Long-term volatility
 
0-27% (11%)

 
Mortality swaps
 
797

 
Discounted cash flow
 
Mortality
 
0-100%  (1%)

Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]
The following table presents quantitative information about significant unobservable inputs used in Level 3 fair value measurements that are developed by the Company, which does not include unobservable Level 3 asset and liability measurements provided by third parties, as of March 31, 2015 and December 31, 2014 (dollars in thousands):
 
March 31, 2015:
 
 
 
Valuation Technique
 
Unobservable Inputs
 
Range (Weighted Average) 
 
Fair Value      
 
 
 
Assets:
 
 
 
 
 
 
 
 
State and political subdivision securities
 
$
5,038

 
Market comparable securities    
 
Liquidity premium
 
1
%
Corporate securities
 
221,072

 
Market comparable securities
 
Liquidity premium
 
0-2% (1%)

U.S. government and agencies
 
27,985

 
Market comparable securities
 
Liquidity premium
 
0-1% (1%)

Funds withheld at interest- embedded derivatives
 
19,769

 
Total return swap
 
Mortality
 
0-100%  (2%)

 
 
 
 
 
 
Lapse
 
0-35%  (7%)

 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
 
 
 
 
 
CVA
 
0-5%  (1%)

 
 
 
 
 
 
Crediting rate
 
2-4%  (3%)

Longevity swaps
 
8,602

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
 
 
 
 
 
Mortality improvement
 
(10%)-10%  (3%)

Liabilities:
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities- embedded derivatives- indexed annuities
 
947,857

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
 
 
 
 
 
Lapse
 
0-35%  (7%)

 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
 
 
 
 
 
Option budget projection
 
2-4%  (3%)

 
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities- embedded derivatives- variable annuities
 
184,413

 
Discounted cash flow
 
Mortality
 
0-100% (2%)

 
 
 
 
 
 
Lapse
 
0-25% (9%)

 
 
 
 
 
 
Withdrawal
 
0-7% (3%)

 
 
 
 
 
 
CVA
 
0-5% (1%)

 
 
 
 
 
 
Long-term volatility
 
0-27% (10%)

Mortality swaps
 
1,276

 
Discounted cash flow
 
Mortality
 
0-100%  (1%)


 
December 31, 2014:
 
Fair Value
 
Valuation Technique(s)
 
Unobservable Input
 
Range (Weighted Average) 
 
 
Assets:
 
 
 
 
 
 
 
 
 
State and political subdivision securities
 
$
4,994

 
Market comparable 
securities
 
Liquidity premium
 
1
%
 
Corporate securities
 
205,392

 
Market comparable
securities
 
Liquidity premium
 
0-2%  (1%)

 
U.S. government and agencies securities
 
28,530

 
Market comparable
securities
 
Liquidity premium
 
0-1%  (1%)

 
Funds withheld at interest- embedded derivatives
 
22,094

 
Total return swap
 
Mortality
 
0-100%  (2%)

 
 
 
 
 
 
 
Lapse
 
0-35%  (7%)

 
 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
 
 
 
 
 
 
CVA
 
0-5%  (1%)

 
 
 
 
 
 
 
Crediting rate
 
2-4%  (3%)

 
Longevity swaps
 
7,727

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
 
 
 
 
 
 
Mortality improvement
 
(10%)-10%  (3%)

 
 
 

 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities- embedded derivatives- indexed annuities
 
925,887

 
Discounted cash flow
 
Mortality
 
0-100% (2%)

 
 
 
 
 
 
 
Lapse
 
0-35% (7%)

 
 
 
 
 
 
 
Withdrawal
 
0-5% (3%)

 
 
 

 
 
 
Option budget projection
 
2-4% (3%)

 
Interest sensitive contract liabilities- embedded derivatives- variable annuities
 
159,279

 
Discounted cash flow
 
Mortality
 
0-100% (2%)

 
 
 
 
 
 
 
Lapse
 
0-25% (8%)

 
 
 
 
 
 
 
Withdrawal
 
0-7% (3%)

 
 
 
 
 
 
 
CVA
 
0-5% (1%)

 
 
 
 
 
 
 
Long-term volatility
 
0-27% (11%)

 
Mortality swaps
 
797

 
Discounted cash flow
 
Mortality
 
0-100%  (1%)

Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Level Transfers [Table Text Block]
The following tables present the transfers between Level 1 and Level 2 during the three months ended March 31, 2015 and 2014 (dollars in thousands):
 
 
Three months ended March 31,
 
 
2015
 
2014
 
 
Transfers from    
Level 1 to
Level 2
 
Transfers from    
Level 2 to
Level 1
 
Transfers from    
Level 1 to
Level 2
 
Transfers from    
Level 2 to
Level 1
Fixed maturity securities - available-for-sale:
 
 
 
 
 
 
 
 
Corporate securities
 
$
625

 
$
5,100

 
$

 
$

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The tables below provide a summary of the changes in fair value of Level 3 assets and liabilities for the three months ended March 31, 2014, as well as the portion of gains or losses included in income for the three months ended March 31, 2014 attributable to unrealized gains or losses related to those assets and liabilities still held at March 31, 2014 (dollars in thousands):
 
For the three months ended March 31, 2014:
 
Fixed maturity securities - available-for-sale
 
 
Corporate
securities
 
Residential mortgage-backed securities
 
Asset-backed securities
 
Commercial mortgage-backed securities
 
U.S. government and agencies securities
Fair value, beginning of period
 
$
1,345,289

 
$
153,505

 
$
471,848

 
$
101,785

 
$
40,919

Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
(1,111
)
 
56

 
2,057

 
372

 
(97
)
Investment related gains (losses), net
 
(161
)
 
106

 
304

 
86

 
(195
)
Claims & other policy benefits
 

 

 

 

 

Interest credited
 

 

 

 

 

Policy acquisition costs and other insurance expenses
 

 

 

 

 

Included in other comprehensive income
 
2,450

 
2,887

 
5,501

 
3,035

 
305

Purchases (1)
 
79,512

 
18,750

 
59,224

 

 
128

Sales(1)
 
(38,747
)
 
(744
)
 
(6,612
)
 
(14,626
)
 

Settlements(1)
 
(51,944
)
 
(6,172
)
 
(6,315
)
 
(279
)
 
(3,029
)
Transfers into Level 3
 
6,930

 
10,563

 
5,948

 

 

Transfers out of Level 3
 
(50,517
)
 
(1,024
)
 
(29,280
)
 

 

Fair value, end of period
 
$
1,291,701

 
$
177,927

 
$
502,675

 
$
90,373

 
$
38,031

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$
(1,062
)
 
$
52

 
$
2,050

 
$
428

 
$
(97
)
Investment related gains (losses), net
 

 

 

 

 

Claims & other policy benefits
 

 

 

 

 

Interest credited
 

 

 

 

 

Policy acquisition costs and other insurance expenses
 

 

 

 

 

 
 
 
Fixed maturity securities - available-for-sale
 
 
 
 
 
 
For the three months ended March 31, 2014 (continued):
 
State and political subdivision securities
 
Other foreign government, supranational and foreign government-sponsored enterprises
 
Funds 
withheld
at interest-
embedded
derivatives
 
Other invested assets- non-redeemable preferred stock
 
Interest sensitive contract liabilities embedded derivatives
Fair value, beginning of period
 
$
43,776

 
$
37,997

 
$
(176,270
)
 
$
4,962

 
$
(868,726
)
Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
12

 

 

 

 

Investment related gains (losses), net
 
(4
)
 

 
77,241

 

 
(23,661
)
Claims & other policy benefits
 

 

 

 

 

Interest credited
 

 

 

 

 
(23,840
)
Policy acquisition costs and other insurance expenses
 

 

 

 

 

Included in other comprehensive income
 
113

 

 

 

 

Purchases(1)
 

 

 

 

 
(15,193
)
Sales(1)
 

 

 

 

 

Settlements(1)
 
(64
)
 
(298
)
 

 

 
19,433

Transfers into Level 3
 

 

 

 

 

Transfers out of Level 3
 

 
(26,542
)
 

 
(4,962
)
 

Fair value, end of period
 
$
43,833

 
$
11,157

 
$
(99,029
)
 
$

 
$
(911,987
)
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$
12

 
$

 
$

 
$

 
$

Investment related gains (losses), net
 

 

 
77,241

 

 
(24,211
)
Claims & other policy benefits
 

 

 

 

 

Interest credited
 

 

 

 

 
(43,273
)
Policy acquisition costs and other insurance expenses
 

 

 

 

 

 
(1)
The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
The tables below provide a summary of the changes in fair value of Level 3 assets and liabilities for the three months ended March 31, 2015, as well as the portion of gains or losses included in income for the three months ended March 31, 2015 attributable to unrealized gains or losses related to those assets and liabilities still held at March 31, 2015 (dollars in thousands):
For the three months ended March 31, 2015:
 
Fixed maturity securities - available-for-sale
 
 
Corporate
securities
 
Residential
mortgage-
backed
securities
 
Asset-backed
securities
 
Commercial    
mortgage-
backed
securities
 
U.S. government
and agencies
securities
 
State
and political
subdivision
securities
Fair value, beginning of period
 
$
1,310,427

 
$
188,094

 
$
572,960

 
$
86,746

 
$
28,529

 
$
42,711

Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
(803
)
 
(140
)
 
1,419

 
594

 
(19
)
 
7

Investment related gains (losses), net
 
(405
)
 
(82
)
 
73

 
87

 
(107
)
 
(4
)
Claims & other policy benefits
 

 

 

 

 

 

Interest credited
 

 

 

 

 

 

Policy acquisition costs and other insurance expenses
 

 

 

 

 

 

Included in other comprehensive income
 
6,069

 
523

 
3,632

 
(310
)
 
176

 
25

Purchases(1)
 
36,900

 
11,439

 
40,991

 

 
121

 

Sales(1)
 

 
(714
)
 
(7,356
)
 
(956
)
 

 

Settlements(1)
 
(59,600
)
 
(5,719
)
 
(4,122
)
 
(5,120
)
 
(944
)
 
(29
)
Transfers into Level 3
 

 
600

 
9,055

 
12,828

 

 

Transfers out of Level 3
 
(5,609
)
 
(1,422
)
 
(7,216
)
 

 

 
(835
)
Fair value, end of period
 
$
1,286,979

 
$
192,579

 
$
609,436

 
$
93,869

 
$
27,756

 
$
41,875

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$
(803
)
 
$
(141
)
 
$
1,399

 
$
589

 
$
(19
)
 
$
7

Investment related gains (losses), net
 

 

 

 

 

 

Claims & other policy benefits
 

 

 

 

 

 

Interest credited
 

 

 

 

 

 

Policy acquisition costs and other insurance expenses
 

 

 

 

 

 

 
For the three months ended March 31, 2015 (continued):
 
Fixed maturity securities
available-for-sale
 
 
 
 
 
 
 
 
 
 
 
 
Other foreign government, supranational and foreign government-sponsored enterprises
 
Funds withheld
at interest-
embedded
derivatives
 
Other invested assets - non-redeemable preferred stock
 
Other assets longevity swaps
 
Interest sensitive contract liabilities embedded derivatives
 
Other liabilities mortality swaps
Fair value, beginning of period
 
$
19,663

 
$
22,094

 
$
7,904

 
$
7,727

 
$
(1,085,166
)
 
$
(797
)
Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 

 

 

 

 

 

Investment related gains (losses), net
 

 
(2,325
)
 

 

 
(25,133
)
 

Claims & other policy benefits
 

 

 

 

 

 

Interest credited
 

 

 

 

 

 

Policy acquisition costs and other insurance expenses
 

 

 

 

 
(29,326
)
 

Included in other comprehensive income
 
182

 

 
88

 
1,821

 

 

Other revenues
 

 

 

 
(946
)
 

 
(479
)
Purchases(1)
 

 

 
29

 

 
(11,644
)
 

Sales(1)
 

 

 

 

 

 

Settlements(1)
 
(310
)
 

 

 

 

 

Transfers into Level 3
 

 

 

 

 
18,999

 

Transfers out of Level 3
 
(4,333
)
 

 
(29
)
 

 

 

Fair value, end of period
 
$
15,202

 
$
19,769

 
$
7,992

 
$
8,602

 
$
(1,132,270
)
 
$
(1,276
)
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$

 
$

 
$

 
$

 
$

 
$

Investment related gains (losses), net
 

 

 

 

 
(28,245
)
 

Other revenues
 

 

 

 
(946
)
 

 
(479
)
Claims & other policy benefits
 

 

 

 

 

 

Interest credited
 

 
(2,325
)
 

 

 
(48,324
)
 

Policy acquisition costs and other insurance expenses
 

 

 

 

 

 


(1)
The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Table Text Block]
The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the periods presented; they are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).
 
 
Carrying Value After Measurement
 
Net Investment Gains (Losses)  
 
 
At March 31,
 
Three months ended March 31,
(dollars in thousands)
 
2015
 
2014
 
2015
 
2014
Mortgage loans(1)
 
$
3,540

 
$
10,660

 
$
50

 
$
380

Limited partnership interests(2)
 
13,667

 

 
(4,509
)
 

 
(1)
Mortgage loans — The impaired mortgage loans presented above were written down to their estimated fair values at the date the impairments were recognized and are reported as losses above. Subsequent improvements in estimated fair value on previously impaired loans recorded through a reduction in the previously established valuation allowance are reported as gains above. Nonrecurring fair value adjustments on mortgage loans are based on the fair value of underlying collateral or discounted cash flows.
(2)
Limited partnership interests — The impaired limited partnership interests presented above were accounted for using the cost method. Impairments on these cost method investments were recognized at estimated fair value determined using the net asset values of the Company’s ownership interest as provided in the financial statements of the investees. The market for these investments has limited activity and price transparency.

Financial Instruments Carrying Amounts And Estimated Fair Value [Table Text Block]
The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments, which were not measured at fair value on a recurring basis, at March 31, 2015 and December 31, 2014 (dollars in thousands). This table excludes any payables or receivables for collateral under repurchase agreements and other transactions. The estimated fair value of the excluded amount approximates carrying value as they equal the amount of cash collateral received/paid.
March 31, 2015:
 
Carrying Value    
 
Estimated 
Fair Value
 
Fair Value Measurement Using:
Level 1           
 
Level 2           
 
Level 3
Assets:
 
 
 
 
 
 
 
 
 
 
Mortgage loans on real estate
 
$
2,913,486

 
$
3,053,041

 
$

 
$

 
$
3,053,041

Policy loans
 
1,284,085

 
1,284,085

 

 
1,284,085

 

Funds withheld at interest(1)
 
5,815,835

 
6,305,645

 

 

 
6,305,645

Cash and cash equivalents(2)
 
706,671

 
706,671

 
706,671

 

 

Short-term investments(2)
 
29,205

 
29,205

 
29,205

 

 

Other invested assets(2)
 
458,423

 
510,287

 
4,637

 
35,446

 
470,204

Accrued investment income
 
283,665

 
283,665

 

 
283,665

 

Liabilities:
 
 
 
 
 
 
 
 
 
 
Interest-sensitive contract liabilities(1)
 
$
9,479,958

 
$
9,830,871

 
$

 
$

 
$
9,830,871

Long-term debt
 
2,313,884

 
2,527,728

 

 

 
2,527,728

Collateral finance and securitization notes
 
774,351

 
684,719

 

 

 
684,719

 
 
 
 
 
 
 
 
 
 
 
December 31, 2014:
 
Carrying Value
 
Estimated
Fair Value
 
Fair Value Measurement Using:
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
 
 
 
Mortgage loans on real estate
 
$
2,712,238

 
$
2,803,942

 
$

 
$

 
$
2,803,942

Policy loans
 
1,284,284

 
1,284,284

 

 
1,284,284

 

Funds withheld at interest(1)
 
5,897,202

 
6,367,165

 

 

 
6,367,165

Cash and cash equivalents(2)
 
745,823

 
745,823

 
745,823

 

 

Short-term investments(2)
 
52,504

 
52,504

 
52,504

 

 

Other invested assets(2)
 
465,720

 
518,261

 
4,674

 
35,446

 
478,141

Accrued investment income
 
261,096

 
261,096

 

 
261,096

 

Liabilities:
 
 
 
 
 
 
 
 
 
 
Interest-sensitive contract liabilities(1)
 
$
9,623,596

 
$
9,666,240

 
$

 
$

 
$
9,666,240

Long-term debt
 
2,314,293

 
2,518,399

 

 

 
2,518,399

Collateral finance and securitization notes
 
782,701

 
674,984

 

 

 
674,984

 
(1)
Carrying values presented herein differ from those presented in the condensed consolidated balance sheets because certain items within the respective financial statement caption are embedded derivatives and are measured at fair value on a recurring basis.
(2)
Carrying values presented herein differ from those presented in the condensed consolidated balance sheets because certain items within the respective financial statement caption are measured at fair value on a recurring basis.